Orthonika Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $615K

  • Investors
  • 2

Orthonika General Information

Description

Developer of a novel total meniscus replacement implant for the knee joint, designed to relieve pain, restore mobility, and improve quality of life for patients with irreparable meniscus injuries. The company offers an advanced, durable implant with a design that closely mimics the natural meniscus, enabling patients with severe knee injuries to regain normal function and reduce reliance on pain management.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 168 Shoreditch High Street
  • London E1 6RA
  • England, United Kingdom
Primary Industry
Surgical Devices
Other Industries
Clinics/Outpatient Services
Corporate Office
  • 168 Shoreditch High Street
  • London E1 6RA
  • England, United Kingdom

Orthonika Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthonika Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Jun-2025 $615K Completed Generating Revenue
9. Grant 02-Jun-2023 Completed Generating Revenue
8. Angel (individual) 28-Jun-2022 Completed Generating Revenue
7. Angel (individual) 06-Nov-2019 Completed Generating Revenue
6. Grant 01-Oct-2019 Completed Generating Revenue
5. Grant 01-Jul-2017 Completed Generating Revenue
4. Angel (individual) 15-May-2017 Completed Generating Revenue
3. Grant 01-Feb-2017 Completed Generating Revenue
2. Seed Round 03-Aug-2015 $234K $234K Completed Generating Revenue
1. University Spin-Out 18-Dec-2014 Completed Startup
To view Orthonika’s complete valuation and funding history, request access »

Orthonika Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 15,699 $0.012361 $29.53 $29.53 $29.53 6.77%
Ordinary 25,000 $0.012361 $6.18 $6.18 $6.18 10.78%
To view Orthonika’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Orthonika Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel total meniscus replacement implant for the knee joint, designed to relieve pain, restore mobility,
Surgical Devices
London, United Kingdom
7 As of 2025

Nijmegen, Netherlands
 

Memphis, TN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orthonika Competitors (2)

One of Orthonika’s 2 competitors is ATRO Medical, a Venture Capital-Backed company based in Nijmegen, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ATRO Medical Venture Capital-Backed Nijmegen, Netherlands
Phoenix Kinetics Venture Capital-Backed Memphis, TN
You’re viewing 2 of 2 competitors. Get the full list »

Orthonika Patents

Orthonika Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11452606-B2 Composite joint implant Active 02-May-2017
US-20200060834-A1 Composite joint implant Active 02-May-2017
US-20230086215-A1 Composite joint implant Inactive 02-May-2017
US-20250025313-A1 Composite joint implant Pending 02-May-2017
EP-3200728-A1 Anatomically designed meniscus implantable devices Active 02-Oct-2014 A61F2/3872
To view Orthonika’s complete patent history, request access »

Orthonika Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orthonika Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
Imperial College London University
To view Orthonika’s complete investors history, request access »

Orthonika FAQs

  • When was Orthonika founded?

    Orthonika was founded in 2014.

  • Where is Orthonika headquartered?

    Orthonika is headquartered in London, United Kingdom.

  • What is the size of Orthonika?

    Orthonika has 7 total employees.

  • What industry is Orthonika in?

    Orthonika’s primary industry is Surgical Devices.

  • Is Orthonika a private or public company?

    Orthonika is a Private company.

  • What is Orthonika’s current revenue?

    The current revenue for Orthonika is .

  • How much funding has Orthonika raised over time?

    Orthonika has raised $3.45M.

  • Who are Orthonika’s investors?

    Innovate UK and Imperial College London have invested in Orthonika.

  • Who are Orthonika’s competitors?

    ATRO Medical and Phoenix Kinetics are competitors of Orthonika.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process